ArticleCureus2025
Robotic-Assisted Hepatectomy After Pancreaticoduodenectomy: A Three-Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the expanding use of minimally invasive hepatectomy (MIH), the proportion of patients who undergo MIH after upper abdominal surgery has been increasing. However, there are few reports showing patients who undergo MIH, particularly robot-assisted hepatectomy (RAH), after pancreatoduodenectomy (PD). Herein, we present three cases involving RAH for hepatic metastatic tumors following PD. Case 1 involves a 49-year-old male patient with metachronous liver metastasis after open PD with portal vein resection and right hemicolectomy for advanced-stage pancreatic head cancer - a solitary small liver metastasis located in the superficial part of segment 5 of the liver. RAH was performed after neoadjuvant chemotherapy. The postoperative course was uneventful, and he is currently alive without recurrence one year and six months after hepatectomy. Case 2 involves a 73-year-old female patient with metachronous liver metastasis after open PD for ampullary cancer - a solitary small liver metastasis located in the superficial part of segment 8 of the liver. RAH was performed. Despite the development of postoperative surgical site infection, she is currently alive without recurrence nine months after hepatectomy. Case 3 involves a 65-year-old female patient with metachronous liver and lung metastasis after open PD with portal vein resection for pancreatic head cancer. RAH was performed for the solitary small liver metastasis located in the superficial part of segment 5 of the liver. She was discharged on postoperative day eight, and she underwent video-assisted thoracic surgery for lung metastasis in the right middle lobe after one month. She is currently alive without recurrence six months after hepatectomy. The median surgical duration and blood loss volume were 198 (141-273) minutes and 52 mL, respectively. There were no cases of conversion. None of the patients developed severe postoperative complications, and the patients had favorable short-term outcomes. RAH after PD can be performed safely by utilizing robotic technology in carefully selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.